The trademark COMERA was filed by Comera Life Sciences, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 9, 2022, and received one opposition filed on September 18, 2022 by BIOFARMA on Likelihood of confusion. the opponent was represented by CABINET GERMAIN & MAUREAU and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 18, 2022
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on December 21, 2022.
Goods And Services
The mark was filed in class 1 with Excipients for use in the manufacture of and as a component of therapeutic compositions.
The mark was filed in class 5 with following description of goods:
Biologic medicines for medical diagnosis or treatment
Monoclonal antibodies or therapeutic proteins for medical diagnosis or treatment
Drug delivery apparatus sold prefilled with biologic medicines or therapeutic compositions
Antibodies.
The mark was filed in class 40 with following description of goods:
Manufacturing, processing, and treating the therapeutic molecules of others
Processing the therapeutic molecules of others, namely, formulation and reformulation of therapeutic compositions
Processing of biopharmaceutical materials for others.
The mark was filed in class 42 with following description of goods:
Scientific design and development of excipients and formulations for use with therapeutic biologics
Scientific research and design in the field of therapeutic formulation development
Consulting in the fields of therapeutic formulation and excipient development
Analysis in the field of molecular biology
Research relating to molecular sciences
Biomedical research services.
The mark was filed in class 45 with Licensing of intellectual property.